Podcasts

Professor Nash and Professor Taylor Interview

Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis: An Integrated Analysis....

February 2019 Monthly Podcast

Cardiovascular Safety During Treatment with Baricitinib in Rheumatoid Arthritis...

Tofacitinib in Combination with Methotrexate in Patients with Rheumatoid Arthritis: Clinical Efficacy, Radiographic and Safety Outcomes from the 24-Month Phase 3 ORAL Scan Study...

January 2019 Monthly Podcast

Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis: An Integrated Analysis...

A Pooled analysis of the Safety of Tofacitinib as Monotherapy or in Combination with Background Conventional Synthetic Disease-Modifying Antirheumatic Drugs in a Phase 3 Rheumatoid Arthritis Population...

December 2018 Monthly Podcast

Influence of Age and Renal Impairment on the Steady State Pharmacokinetics of Filgotinib, a Selective JAK1 Inhibitor...

Evaluation of the Short-, Mid-, and Long-term Effects of Tofacitinib on Lymphocytes in Patients with Rheumatoid Arthritis...

Professor Nash and Florence Namour Interview

Influence of Age and Renal Impairment on the Steady State Pharmacokinetics of Filgotinib...

November 2018 Monthly Podcast

Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids...

Herpes zoster in Tofacitinib: Risk is Further Increased with Glucocorticoids but not Methotrexate...